| Review on the in vitro interaction of insulin glargine with the insulin/insulin-like growth factor system: potential implications for metabolic and mitogenic activities. | |
| | |
MedLine Citation:
|
PMID: 20938889 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Insulin analogues provide clinically important benefits for people with diabetes, including more predictable action profiles and lower risk of hypoglycemia compared with human insulin. However, it has been suggested that certain insulin analogues may lead to greater activation of insulin-like growth factor-1 (IGF-1) signaling, with risk for adverse mitogenic effects. This article aims to critically review studies on the mitogenic effects of the insulin analogue insulin glargine (glargine) and its metabolites. A review of in vitro studies suggests that glargine may stimulate mitogenic activity in some cell lines at supraphysiological concentrations (nanomolar/micromolar concentrations). Mitogenicity appeared to be related to the expression of the IGF-1 receptor, being present in cells expressing high levels of the receptor and absent in cells with limited or no IGF-1 receptor expression. In animal studies, glargine did not promote tumor growth, despite administration at supraphysiological concentrations (nanomolar/micromolar), which are unlikely to be observed in clinical practice because the doses needed to produce these concentrations are liable to lead to hypoglycemia. Furthermore, glargine in vivo is rapidly transformed into its metabolites, the metabolic and mitogenic characteristics of which have been shown to be broadly equal to those of human insulin. Thus, the suggestion of increased relative mitogenic potency of insulin glargine seen in some cell lines does not appear to carry over to the in vivo situation in animals and humans. |
| | |
Authors:
|
T P Ciaraldi; T Sasaoka |
Related Documents
:
|
20566589 - Erythropoietin and vascular endothelial growth factor as risk markers for severe hypogl... 3883109 - Severe hypoglycaemia. a one-year prospective survey in wollongong. 9083709 - Improved mealtime treatment of diabetes mellitus using an insulin analogue. multicenter... 14586649 - Severe transient hyperinsulinaemic hypoglycaemia: two neonates without predisposing fac... 991619 - Changes in plasma and urine magnesium following subcutaneous insulin. 11476359 - Italian multicentre study of intensive therapy with insulin lispro in 1184 patients wit... 8985139 - Basement membrane abnormalities in human eyes with diabetic retinopathy. 7980479 - Subcellular localization and trafficking of the glut4 glucose transporter isoform in in... 3549699 - The snf3 gene is required for high-affinity glucose transport in saccharomyces cerevisiae. |
Publication Detail:
|
Type: Journal Article Date: 2010-10-11 |
Journal Detail:
|
Title: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme Volume: 43 ISSN: 1439-4286 ISO Abbreviation: Horm. Metab. Res. Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-01-05 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0177722 Medline TA: Horm Metab Res Country: Germany |
Other Details:
|
Languages: eng Pagination: 1-10 Citation Subset: IM |
Copyright Information:
|
© Georg Thieme Verlag KG Stuttgart · New York. |
Affiliation:
|
Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. tciaraldi@ucsd.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: High-efficient nonviral transfection of the rat thyroid cell line FRTL-5.
Next Document: Hepatic VLDL-TG production and MTP gene expression are decreased in ovariectomized rats: effects of ...